Cosmos Health Inc.（简称Cosmos Health）近日宣布，正式任命国际知名的AI驱动药物研发及临床阶段生物技术专家Dimitrios Iliopoulos博士加入公司顾问委员会。Iliopoulos博士在人工智能辅助药物发现和临床阶段生物技术研发领域拥有深厚造诣，其加入将显著提升Cosmos Health在创新药物开发方面的战略布局与技术实力。
此次任命凸显了Cosmos Health致力于整合前沿科技与医疗健康的战略方向，通过引入顶尖行业专家，进一步强化公司在全球医疗创新领域的竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.